The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening

European Respiratory Journal

Volumn 54, Issue 2, 2019, Pages

  Gracie, Kathryn ^a   Kennedy, Martyn P T ^b   Esterbrook, Georgina ^c   Smith, Graham ^c   Blaxill, Parry ^c   Ameri, Ali T ^c   Rodger, Kirsty I A ^b   Robson, Jonathan M ^b   Paramasivam, Elankumaran ^b   Naseer, Rehan ^d   Smith, Peter ^e   Ellames, Deborah A B ^b   Hawramy, Bana ^b   Callister, Matthew E J ^b  

^a YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^d CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

^e Airedale NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANONYMISED DATA; CANCER CENTER; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; LETTER; LOW ENERGY RADIATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; SMOKING; UNITED KINGDOM; VERY ELDERLY; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; PULMONOLOGY; RISK ASSESSMENT; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY MEDICINE; RISK ASSESSMENT; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; UNITED KINGDOM;

EID: 85071347462     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02221-2018     Document Type: Letter

References (17)

1. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
2. Moyer VA. U.S. Preventive Services Task Force. Screening for lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014; 160: 330-338.
3. Van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-2229
4. De Koning H, Van Der Aalst C, Ten Haaf K, et al. Effects of volume CT lung cancer screening: Mortality results of the NELSON randomised-controlled population based trial. (IASLC 19th World Conference on Lung Cancer, Toronto, Canada, PL02.05) J Thorac Oncol 2018; 13: Suppl. 10, S185.
5. Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening. Lancet Oncol 2017; 18: E754-e766.
6. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 160: 311-320.
7. Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen 2012; 19: 154-156.
8. Cassidy A, Myles JP, Van Tongeren M, et al. The LLP risk model: An individual risk prediction model for lung cancer. Br J Cancer 2008; 98: 270-276.
9. Field JK, Duffy SW, Baldwin DR, et al. The UK Lung Cancer Screening Trial: A pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 2016; 20: 1-146.
10. Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368: 728-736.
11. Tammemagi MC, Church TR, Hocking WG, et al. Evaluation of lung cancer risks at which to screen ever- and never-smokers: Screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014; 11: E1001764.
12. Ten Haff K, Van Rosmalen J, De Koning HJ. Lung cancer detectability by test, histology, stage, and gender: Estimates from the NLST and PLCO Trials. Cancer Epidemiol Biomarkers Prev 2015; 24: 154-161.
13. Roy Castle Lung Cancer Foundation, Liverpool Lung Project (LLP). MyLungRisk V2.0. www.mylungrisk.org Date last accessed: March 4, 2019.
14. Brock University, Canada. Lung Cancer Screening and Risk Prediction: Lung Cancer Risk Calculators. https:// brocku.ca/lung-cancer-screening-and-risk-prediction/risk-calculators/ Date last accessed: March 4, 2019.
15. Quaife SL, Ruparel M, Beeken RJ, et al. The Lung Screen Uptake Trial (LSUT): Protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and "hard-to-reach" patients. BMC Cancer 2016; 16: 281.
16. Crosbie PA, Balata H, Evison M, et al. Implementing lung cancer screening: Baseline results from a community-based "Lung Health Check" pilot in deprived areas of Manchester. Thorax 2019; 74: 405-409.
17. Kennedy MPT, Cheyne L, Darby M, et al. Lung cancer stage-shift following symptom awareness campaign. Thorax 2018; 73: 1128-1136.